Compare DHT & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DHT | VCYT |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.6B |
| IPO Year | 2005 | 2013 |
| Metric | DHT | VCYT |
|---|---|---|
| Price | $17.57 | $38.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $19.33 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 2.8M | 833.6K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 5.36% | N/A |
| EPS Growth | N/A | ★ 164.52 |
| EPS | N/A | ★ 0.35 |
| Revenue | N/A | N/A |
| Revenue This Year | $8.85 | $13.76 |
| Revenue Next Year | N/A | $12.35 |
| P/E Ratio | ★ $12.73 | $110.87 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.61 | $22.61 |
| 52 Week High | $20.55 | $50.71 |
| Indicator | DHT | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 41.15 | 59.80 |
| Support Level | $16.98 | $37.98 |
| Resistance Level | $18.80 | $39.88 |
| Average True Range (ATR) | 0.62 | 1.99 |
| MACD | -0.14 | 0.35 |
| Stochastic Oscillator | 7.55 | 66.77 |
DHT Holdings Inc is a crude oil tanker company. The company's primary business is operating a fleet of crude oil tankers, with a secondary activity of providing technical management services. Its fleet trades internationally and consists of VLCC crude oil tankers. The group generates revenues from time charter and spot market operations. It operates vessels through its subsidiary management companies in Monaco, Norway, Singapore, and India. The company generates the majority of its revenue from Voyage charter revenues.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).